TOP TIERMARKET NEWSWIRE
SEC Form 4 history

KARYOPHARM THERAPEUT (KPTI) insider trades

KARYOPHARM THERAPEUT (KPTI) insider trading activity (SEC Form 4). Over the trailing 90 days, KPTI insiders filed 0 purchases totalling $0 and 3 sales totalling $2K — net SELLING of $2K. Most recent filing: Oct 19, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.

Public view, delayed 4h. Real-time alerting on insider filings is a Pro feature.Open in the live terminal →
Buys (90d)
0
$0
Sells (90d)
3
$2K
Net (90d)
-$2K
net selling
Most recent
Oct 19, 2026

Recent transactions

FiledInsiderRoleTypeSharesPriceValue
Oct 19, 2026Abate KristinChief Accounting OfficerS Sale—$0.34$2Kfiling
Oct 2, 2026Abate KristinChief Accounting OfficerS Sale—$1.19$450filing
Sep 2, 2026Abate KristinChief Accounting OfficerS Sale—$2.02$38filing
Jul 30, 2026Poulton StuartEVP, Chief Development OfficerS Sale—$7.10$1Kfiling
May 15, 2026Cheng Sohanya RoshanEVP, Chief Commercial OfficerS Sale—$9.50$3Kfiling
May 15, 2026Rangwala ReshmaEVP, Chief Medical OfficerS Sale—$9.50$4Kfiling
May 15, 2026Poulton StuartEVP, Chief Development OfficerS Sale—$9.50$4Kfiling
May 15, 2026Mano MichaelEVP, CLO, SecretaryS Sale—$9.50$3Kfiling
May 15, 2026Paulson Richard A.Pres, CEOS Sale—$9.50$21Kfiling
May 15, 2026Abate KristinChief Accounting OfficerS Sale—$9.50$504filing